DENVER -- A new study led by researchers at National Jewish Health has revealed that, while a wide range of viruses can cause lower respiratory tract illnesses (LRIs) in infants, certain viruses and ...

Bristol Myers Squibb (NYSE: BMY) today announced that the Phase 3 EXCALIBER-RRMM study evaluating iberdomide, an investigational cereblon E3 ligase modulator (CELMoD™), combined with standard ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. In what researchers hope could be a case of 1 + ...

Some additives in ultraprocessed foods are known to be harmful to the body – but what about when these ingredients are combined? A new study, published in the journal PLOS Medicine, revealed that the ...

A combination of two widely available drugs could significantly reduce deaths from heart attacks, a study has found. New evidence shows combining statins with ezetimibe immediately is more effective ...

On Wednesday, Bristol Myers Squibb & Co (NYSE:BMY) announced the final analysis of overall survival (OS) from the Phase 3 CheckMate -816 study, which evaluated Opdivo (nivolumab) in combination with ...

A new AICPA guide aims to demystify accounting and valuations in mergers and acquisitions and related transactions. Valuation specialists, preparers of financial statements, and independent auditors ...

Only two puzzles in SH2R have a fully randomized solution. The rest are consistent between runs, although they're often dependent upon puzzle difficulty. There are no negative consequences to skipping ...

Surufatinib plus PD-1/L1 inhibitors as maintenance therapy following first line (1L) platinum-based chemotherapy combined with PD-1/L1 inhibitors in patients (pts) with extensive-stage small cell lung ...